ArticleMedicine2025
Association between triglyceride-glucose index, modified triglyceride-glucose indices and hearing loss among US adults: A cross-sectional study.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The relationship between the triglyceride-glucose (TyG) index, modified TyG indices, and hearing loss in the US population is not well comprehended. The cross-sectional study made use of data collected from the National Health and Nutrition Examination Survey database between 2007 and 2018. Multivariable logistic regression models were used to investigate the relationships between the TyG index, its modified versions, and hearing loss. Potential confounding factors including demographic characteristics, smoking status, noise exposure history, and relevant comorbidities were also adjusted for model. Additionally, stratified subgroup analyses were performed to further assess the strength and consistency of associations across different population characteristics. Of the 2197 included participants, 144 (6.6%) had low-frequency hearing loss, 221 (10.1%) had speech-frequency hearing loss, and 642 (29.2%) had high-frequency hearing loss (HFHL). In the fully adjusted model, the TyG-BMI index in the third quartile (Q3) and fourth quartile (Q4) was significantly associated with HFHL, with OR (95% CI) of 2.261 (1.112, 4.599) and 2.865 (1.087, 7.552), respectively. Similarly, the TyG-WC index demonstrated significant associations with HFHL in Q3 and Q4, with OR (95% CI) of 2.201 (1.139, 4.253) and 2.470 (1.227, 4.971), respectively. Subgroup analysis indicated that these associations were more prominent among individuals with diabetes. Increased TyG-BMI and TyG-WC indices were strongly linked to a greater risk of HFHL. The modified TyG indices demonstrated superior clinical utility compared to the traditional TyG index.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.